Innoviva (INVA) Common Equity (2009 - 2026)

Innoviva (INVA) has 18 years of Common Equity data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 107.4% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 107.4% YoY), and the FY2025 full-year result was $1.2 billion, up 69.69% from the prior year.
• Common Equity for Q1 2026 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.3 billion in Q1 2026 and bottomed at $552.2 million in Q1 2022.
• The 5-year median for Common Equity is $665.5 million (2024), against an average of $727.0 million.
• The widest annual swing landed in 2022, when Common Equity fell 20.74%; it then soared 107.4% in 2026.
• A 5-year view of Common Equity shows it stood at $565.8 million in 2022, then climbed by 19.29% to $675.0 million in 2023, then gained by 2.4% to $691.2 million in 2024, then soared by 69.69% to $1.2 billion in 2025, then climbed by 14.39% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison